Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

Report Code: BIO150B

Publish Date: Oct 2017

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global liquid biopsy market should reach $4.5 billion by 2022 from $1.5 billion in 2017 at a compound annual growth rate (CAGR) of 24.2%, from 2017 to 2022.

Report Includes

  • An overview of the global markets for liquid biopsy research tools, services, and diagnostics
  • Analyses of global market trends, with data from 2015 and 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Coverage of how these technologies can reduce invasive tumor biopsies, drive early cancer detection, and support precise drug administration
  • Detailed analysis of liquid biopsy workflow technologies, biomarker classes, sample types, and research tools reagents
  • Breakdowns of the market by product, product type, application, end use industry, technology, and indication
  • Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities
  • Profiles of major players in the industry

Report Scope

The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents and companies.The market sizes for liquid biopsy diagnostics are given for the years 2015, 2016, 2017 (estimated) and 2022 (forecasted).

This report reviews liquid biopsy biomarkers and technologies and provides background on why liquid biopsy is increasingly viewed as a replacement for, or a companion to, tissue biopsy.It then discusses several of the significant large-scale research initiatives that are contributing to liquid biopsy development.Market driving forces are also discussed.

The structure of several important industry subsectors is reviewed, as well as major industry acquisitions and strategic alliances from January 2016 through July 2017.Industry subsectors analyzed includenext-generation sequencing(NGS) instruments, droplet digital PCR, target enrichment and amplification, single-cell DNA polymerase, prenatal screening, liquid biopsy, direct to consumer, and clinical laboratory.

The market for liquid biopsy diagnostics is analyzed in depth.The market is analyzed by application (cancer, reproductive health, transplant), biomarker type (nucleic acids, cells, extracellular vesicles, proteins), analysis platform (microarray, NGS, PCR, proteomics and other), analysis purpose (screening/early detection, diagnosis, therapy guidance, monitoring) and geography (North America, Europe, Asia-Pacific, Rest of World).

Market data cover the years 2015, 2016, 2017 (estimated) and 2022 (forecasted).

More than 165 companies in the liquid biopsy industry are profiled in this report.

BCC Research provides a summary of the main industry acquisitions and strategic alliances from January 2016 through July 2017, including key alliance trends.

Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? Explore Offers

Analyst Credentials

John Bergin has produced successful and highly regarded market research reports in the life science industry for BCC research for more than 10 years. Mr. Bergin has held business development and international sales and marketing positions with Corning Inc., an advanced materials company. He has also held executive management positions with IBC Advanced Technologies, a molecular recognition company specializing in separations. Mr. Bergin's extensive expertise in commercializing new technologies is reflected in his market research reports.

Mr. Bergin received a BS degree in Chemistry and Masters of Business Administration (MBA) degree from Brigham Young University and an MS degree in biotechnology from Johns Hopkins University. John Bergin is a pseudonym of the author.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets282Free
Chapter- 1: Introduction8Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Overview7Free
Chapter- 4: Technology Background 18Free
Chapter- 5: Liquid Biopsy Initiatives5Free
Chapter- 6: Liquid Biopsy Applications8Free
Chapter- 7: Liquid Biopsy Industry45Free
Chapter- 8: Acquisitions and Strategic Alliances21Free
Chapter- 9: Liquid Biopsy Markets50Free
Chapter- 10: Patent Review5Free
Chapter- 11: Company Profiles112Free

Related Reports

Global Biochip Markets: Microarrays and Lab-on-a-Chip

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO049G

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

Epigenetics: Technologies and Global Markets

Published - Mar 2025 | Publisher - BCC Publishing | Code - PHM044D

The global market for epigenetics research tools and reagents, IVDs and therapeutics is expected to grow from $4.8 billion in 2024 to $8.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.8% from 2024 through 2029.

Biomarkers: Technologies and Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - BIO061G

The global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% from 2024 through 2029.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 87

  • Summary Table: Global Liquid Biopsy Market, by Disease Class, Through 2022
  • Table 1: Liquid Biopsy Sample Types
  • Table 2: Liquid Biopsy Report Scope
  • Table 3: Global Liquid Biopsy Market, by Analysis Type, Through 2022
  • Table 4: Growth Driving Forces
  • Table 5: Key Trends in Liquid Biopsy Market
  • Table 6: Liquid Biopsy Industry Subsectors
  • Table 7: Liquid Biopsy Biomarker Classes
  • Table 8: Single-Cell Analysis to Identify Cancer Driver Mutations
  • Table 9: Genomics-Based Oncology Workflow
  • Table 10: Unique Challenges of CTC Capture and Analysis
Sample Report

Recent Reports

Chromatography in Pharmaceuticals and Biotechnology: Global Markets

Published - Aug 2025 | Publisher - BCC Publishing | Code - BIO163B

The global market for chromatography in pharmaceuticals and biotechnology is estimated to grow from $13.3 billion in 2025 to reach $19.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2030.

Genome Editing: Technologies and Global Markets

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO146D

The global market for genome editing is expected to grow from $10.8 billion in 2025 and is projected to reach $23.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 16.9% during the forecast period of 2025 to 2030.

Global Assisted Reproductive Technologies Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO270A

The report provides an analysis of the global assisted reproductive technologies market and analyzes market trends. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030. The market in this report is segmented into procedure, product, end user, and region. The report focuses on the significant trends, challenges and technological advancements that alter the market and vendor landscape.

Global Irritable Bowel Syndrome and Inflammatory Bowel Disease Therapeutics Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO269A

The global market for irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) therapeutics is expected to grow from $33.3 billion in 2025 and is projected to reach $52.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.6% during the forecast period of 2025 to 2030.

Global DNA Forensics Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO266A

The global market for DNA forensics is projected to grow from an estimated $3.3 billion in 2025 to $4.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2030.

Published - Jan-2016| Analyst - John Bergin| Code - BIO150A

Report Highlights

The global liquid biopsy market should reach nearly $4.5 billion in 2020 from $1.6 billion in 2015, registering a CAGR of 22.3% for the period of 2015-2020.

Report Includes

  • An overview of the global markets for liquid biopsy research tools, services, and diagnostics
  • Analyses of global market trends, with data for 2014, estimates for 2015, and projections of CAGRs through 2020
  • Coverage of how these technologies can reduce invasive tumor biopsies, drive early cancer detection, and support precise drug administration
  • Detailed analysis of liquid biopsy workflow technologies, biomarker classes, sample types, research tools reagents, and more
  • Breakdowns of the market by product, product type, application, end use industry, technology, indication, as well as many others
  • Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities
  • Profiles of major players in the industry

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
Customize Report